Results 21 to 30 of about 1,674,400 (206)

Incremental diagnostic role of left atrial strain analysis in thrombotic risk assessment of nonvalvular atrial fibrillation patients planned for electrical cardioversion

The International Journal of Cardiovascular Imaging, 2021
During the COVID-19 pandemic, transesophageal echocardiography (TEE) for left atrial appendage thrombosis (LAAT) detection should be limited to situations of absolute necessity. We sought to identify the main conventional and functional echocardiographic
A. Sonaglioni, M. Lombardo, G. Nicolosi, Elisabetta Rigamonti, C. Anza'   +4 more
semanticscholar   +1 more source

Direct oral anticoagulants for electrical cardioversion

Кардиоваскулярная терапия и профилактика, 2021
The article discusses the issues of anticoagulant preparation for elective electrical cardioversion in patients with persistent atrial fibrillation. Updated preparation regimens for electrical cardioversion are proposed, as well as the potential of using
A. N. Volovchenko, D. A. Andreev, D. F. Mesitskaya   +2 more
doaj   +1 more source

Effect of electrical cardioversion on 1‐year outcomes in patients with early recurrence after catheter ablation for atrial fibrillation

Clinical Cardiology, 2021
Atrial fibrillation (AF) recurrence is common in the 3‐month blanking‐period after catheter ablation, during which electrical cardioversion (ECV) is usually performed to restore sinus rhythm.
Zheng Dong, Xin Du, Xiao-Xia Hou, Liu He, Jian-zeng Dong, Changsheng Ma   +5 more
semanticscholar   +1 more source

Impact of Additional Transthoracic Electrical Cardioversion on Cardiac Function and Atrial Fibrillation Recurrence in Patients with Persistent Atrial Fibrillation Who Underwent Radiofrequency Catheter Ablation [PDF]

Cardiology Research and Practice, 2016
Backgrounds and Objective. During the procession of radiofrequency catheter ablation (RFCA) in persistent atrial fibrillation (AF), transthoracic electrical cardioversion (ECV) is required to terminate AF.
Deguo Wang, Fengxiang Zhang, Wang An-cai
openalex   +2 more sources

Atrial fibrillatory rate as predictor of recurrence of atrial fibrillation in horses treated medically or with electrical cardioversion

Equine Veterinary Journal, 2021
Summary Background The recurrence rate of atrial fibrillation (AF) in horses after cardioversion to sinus rhythm (SR) is relatively high. Atrial fibrillatory rate (AFR) derived from surface ECG is considered a biomarker for electrical remodelling and ...
R. Buhl, E. Hesselkilde, Helena Carstensen, C. Hopster‐Iversen, G. van Loon, A. Decloedt, G. van Steenkiste, C. Marr, V. Reef, C. Schwarzwald, K. Mitchell, K. Nostell, N. Nógrádi, S. Nielsen, J. Carlson, P. Platonov   +15 more
semanticscholar   +1 more source

Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm

Journal of Clinical Medicine, 2021
Background: Antiarrhythmic drugs (AADs) are frequently initiated in patients with persistent atrial fibrillation (AF) prior to electrical cardioversion (ECV), achieving pharmacological cardioversion (PCV) in some cases.
Amine El Amrani, X. Viñolas, M. A. Arias, V. Bazan, P. Valdovinos, J. Alegret   +5 more
semanticscholar   +1 more source

Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial. [PDF]

, 2020
Introduction  This X-VeRT (eXplore the efficacy and safety of once-daily oral riVaroxaban for the prevention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion) substudy evaluated the effects of ...
Camm, AJ, Cappato, R, Ezekowitz, MD, Hohnloser, SH, Kirchhof, P, Meng, IL, Purmah, Y, Schiffer, S, Schulz, A, Wosnitza, M   +9 more
core   +1 more source

Cardioverting acute atrial fibrillation and the risk of thromboembolism: not all patients are created equal [PDF]

, 2017
Current guidelines support the well-established clinical practice that patients who present with atrial fibrillation (AF) of less than 48 hours duration should be considered for cardioversion, even in the absence of pre-existing anticoagulation. However,
Rankin, Alastair J., Rankin, Stephen H.
core   +1 more source

Short and Intermediate Term Outcomes of the Convergent Procedure: Initial Experience in a Tertiary Referral Center [PDF]

, 2020
PURPOSE: The Convergent procedure is a hybrid, multidisciplinary treatment for symptomatic atrial fibrillation (AF) consisting of minimally invasive surgical epicardial ablation and percutaneous/catheter endocardial ablation.
Hirsh, Jeffrey, Lantz, Gurion, Lee, Lawrence S., Mahlow, Jeremy, Tonks, Robert   +4 more
core   +1 more source

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021
Background Anticoagulation is indicated for 4 weeks after cardioversion in patients with atrial fibrillation/flutter. We sought to examine whether there is evidence of sex or racial disparity in anticoagulant prescription following cardioversion, and ...
A. Mentias, S. Nakhla, M. Desai, O. Wazni, V. Menon, S. Kapadia, M. V. Vaughan Sarrazin   +6 more
semanticscholar   +1 more source